Nurse-Led Telehealth Frailty Management in Older Adults

ConditionFrailty
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorKutahya Health Sciences University

About this trial

Frailty is an important geriatric syndrome associated with reduced physiological reserve, functional decline, falls, hospitalization, and increased health care use among older adults. This randomized controlled trial aims to evaluate the effect of a nurse-led telehealth-supported multicomponent frailty management program on frailty level and functional status in older adults living at home.

The study will be conducted as a single-center, two-arm, parallel-group randomized controlled trial. A total of 100 older adults aged 65 years and older who are living at home and are frail or at risk of frailty will be randomly assigned to either the intervention group or the control group in a 1:1 ratio.

Participants in the intervention group will receive an 6-week nurse-led telehealth-supported frailty management program, including weekly telephone counseling and individualized follow-up. Participants in the control group will continue usual care. Data will be collected at baseline, at 6 weeks, and at 18 weeks. The primary outcome is frailty level measured using the FRAIL Scale. Secondary outcomes include functional status, depressive symptoms, number of falls, emergency department visits, and hospitalizations.

Eligibility criteria

Qualifiers

Aged 65 years or older

Living at home and not receiving institutional care

Frail or at risk of frailty

Having sufficient hearing and cognitive ability to communicate by telephone

Disqualifiers

Having advanced cognitive impairment such as dementia

Having hearing or speech problems that prevent communication

Being bedridden

Being in the terminal stage of illness

Trial design

Treatments tested in this trial

  • Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program

Treatment groups

100 Participants
are divided into 2 treatment groups